Ocrelizumab

Common brands: Ocrevus, Baclofen, Baclofen (Intrathecal), Fleqsuvy, Lioresal (Baclofen)

Top reporter: Genentech, Inc.

CD20-directed Cytolytic Antibody [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]gamma-Aminobutyric Acid-ergic Agonist [EPC]Potassium Channel Blocker [EPC]
60,647
Total Reports
34,366
Serious Reports
1,490
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.46%)

Patient Demographics

Male
14,414
Female
38,411

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Ocrelizumab.

# Reaction Reports % of Total
1 COVID-19 11,553
15.0%
2 FATIGUE 6,150
8.0%
3 URINARY TRACT INFECTION 3,760
4.9%
4 HEADACHE 3,229
4.2%
5 MULTIPLE SCLEROSIS 2,963
3.9%
6 ASTHENIA 2,685
3.5%
7 GAIT DISTURBANCE 2,681
3.5%
8 MULTIPLE SCLEROSIS RELAPSE 2,661
3.5%
9 NASOPHARYNGITIS 2,549
3.3%
10 PAIN 2,500
3.3%
11 FALL 2,497
3.2%
12 PNEUMONIA 2,418
3.1%
13 OFF LABEL USE 2,405
3.1%
14 DRUG INEFFECTIVE 2,396
3.1%
15 INFUSION RELATED REACTION 2,177
2.8%
16 INFLUENZA 2,006
2.6%
17 COUGH 1,810
2.4%
18 PYREXIA 1,762
2.3%
19 NAUSEA 1,752
2.3%
20 DIZZINESS 1,715
2.2%
21 MUSCULAR WEAKNESS 1,663
2.2%
22 PRURITUS 1,660
2.2%
23 PAIN IN EXTREMITY 1,608
2.1%
24 HYPOAESTHESIA 1,601
2.1%
25 MALAISE 1,565
2.0%
26 HERPES ZOSTER 1,455
1.9%
27 SARS-COV-2 TEST POSITIVE 1,427
1.9%
28 NO ADVERSE EVENT 1,416
1.8%
29 DYSPNOEA 1,413
1.8%
30 THROAT IRRITATION 1,370
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.